The session aims to highlight the latest data, innovations and examples of good practice in relation to HIV and sexually transmitted infections (STIs), taking into consideration the current COVID-19 pandemic.

While HIV responses worldwide urgently need to revitalize their focus on the HIV prevention, diagnosis and treatment needs of key populations, the broader health needs of key populations also need to be recognized and addressed. Key population health needs extend to ensuring access to appropriate services for viral hepatitis and sexually transmitted infections (STIs) along with a broader package that includes mental health, transition care, substance use and sexual and reproductive health services. This session will explore new and emerging World Health Organization recommendations related to key populations across HIV, viral hepatitis, STIs and broader health. It will discuss the latest evidence and programmatic examples of providing person centered services to key populations in different settings through integrated services, service delivery, programming and funding that harnesses the synergies between the three diseases as well as broader health.

This session will highlight progress towards a 2020 update of key elements of consolidated WHO guidance on HIV diagnostics, treatment and care. It will explore new evidence and policy directions related to emerging ARV toxicities; new guidelines on the diagnosis and management of Histoplasmosis among people living with HIV, non-communicable diseases and HIV integration, developments in pediatric and adolescents treatment; and viral load testing frequency and thresholds and early infant diagnosis. The session will invite diverse stakeholders to explore the urgency and challenges of adopting HIV treatment guidance, and expanding access to reliable viral load testing, in an increasingly complex context.

The session aims to highlight the latest data, innovations and examples of good practice in relation to HIV and sexually transmitted infections (STIs), taking into consideration the current COVID-19 pandemic.

While HIV responses worldwide urgently need to revitalize their focus on the HIV prevention, diagnosis and treatment needs of key populations, the broader health needs of key populations also need to be recognized and addressed. Key population health needs extend to ensuring access to appropriate services for viral hepatitis and sexually transmitted infections (STIs) along with a broader package that includes mental health, transition care, substance use and sexual and reproductive health services. This session will explore new and emerging World Health Organization recommendations related to key populations across HIV, viral hepatitis, STIs and broader health. It will discuss the latest evidence and programmatic examples of providing person centered services to key populations in different settings through integrated services, service delivery, programming and funding that harnesses the synergies between the three diseases as well as broader health.

This session will highlight progress towards a 2020 update of key elements of consolidated WHO guidance on HIV diagnostics, treatment and care. It will explore new evidence and policy directions related to emerging ARV toxicities; new guidelines on the diagnosis and management of Histoplasmosis among people living with HIV, non-communicable diseases and HIV integration, developments in pediatric and adolescents treatment; and viral load testing frequency and thresholds and early infant diagnosis. The session will invite diverse stakeholders to explore the urgency and challenges of adopting HIV treatment guidance, and expanding access to reliable viral load testing, in an increasingly complex context.